17th Virtual Thoracic Oncology Spring Symposium
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
Programme
Session 1:
Healthcare policy
chair persons: Jan van Meerbeeck & Veerle Surmont
European Cancer Organisations’ Essential Requirements for Quality Lung Cancer Care
Yolande Lievens, UZ Ghent, Belgium
The Dutch Lung Cancer Audit: lessons learnt
Hans Smit, Arnhem, the Netherlands
Session 2:
Radiotherapy
chair persons: Charlotte Billiet & Yolande Lievens
Hippocampal avoidance during PCI: a multicenter international randomised trial
José Belderbos, Amsterdam, the Netherlands
Is watchful waiting a valid alternative for PCI in SCLC?
Corinne Faivre-Finn, Manchester, United Kingdom
Session 3:
Systemic disease and treatment
chair persons: Annelies Janssens & Karim Vermaelen
Resistance after immunotherapy?
Laurent Greillier, Marseille, France
pro/con DEBATE – adjuvant osimertinib
PRO: Lizza Hendriks, Maastricht, the Netherlands
CON: Jacques Cadranel, Paris, France
TERAVOLT: results of an international survey on the impact of COVID-19 in patients with thoracic cancer
Marina Garassino, Chicago, US
Closure
Programme
Session 1:
Healthcare policy
chair persons: Jan van Meerbeeck & Veerle Surmont
European Cancer Organisations’ Essential Requirements for Quality Lung Cancer Care
Yolande Lievens, UZ Ghent, Belgium
The Dutch Lung Cancer Audit: lessons learnt
Hans Smit, Arnhem, the Netherlands
Session 2:
Radiotherapy
chair persons: Charlotte Billiet & Yolande Lievens
Hippocampal avoidance during PCI: a multicenter international randomised trial
José Belderbos, Amsterdam, the Netherlands
Is watchful waiting a valid alternative for PCI in SCLC?
Corinne Faivre-Finn, Manchester, United Kingdom
Session 3:
Systemic disease and treatment
chair persons: Annelies Janssens & Karim Vermaelen
Resistance after immunotherapy?
Laurent Greillier, Marseille, France
pro/con DEBATE – adjuvant osimertinib
PRO: Lizza Hendriks, Maastricht, the Netherlands
CON: Jacques Cadranel, Paris, France
TERAVOLT: results of an international survey on the impact of COVID-19 in patients with thoracic cancer
Marina Garassino, Chicago, US
Closure